A Study of the Safety and Efficacy of Infliximab in Patients With Psoriasis
Clinical trial NCT00106834 · COMPLETED
Trial details
- NCT number
- NCT00106834
- Sponsor
- Centocor, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 378
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.